We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Artificial Intelligence Helps Cancer Patients Start Radiation Therapy Sooner

By HospiMedica International staff writers
Posted on 19 Mar 2020
A new study by researchers from UT Southwestern’s Medical Artificial Intelligence and Automation (MAIA) Lab (Dallas, TX, USA) has demonstrated that artificial intelligence (AI) can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.

Patients generally have to wait for several days to a week before beginning therapy as their doctors manually develop treatment plans. More...
Developing a sophisticated treatment plan can be a time-consuming and tedious process that involves careful review of the patient’s imaging data and several phases of feedback within the medical team. However, new research from UT Southwestern now shows how enhanced deep-learning models can streamline this process down to a fraction of a second.

The researchers explored various methods of using AI to improve multiple facets of radiation therapy – from the initial dosage plans required before the treatment can begin to the dose recalculations that occur as the plan progresses. Their study on dose prediction demonstrated AI’s ability to produce optimal treatment plans within five-hundredths of a second after receiving clinical data for patients.

The researchers achieved this by feeding the data for 70 prostate cancer patients into four deep-learning models. Through repetition, the AI learned to develop 3D renderings of how best to distribute the radiation in each patient. Each model accurately predicted the treatment plans developed by the medical team. The study builds upon other MAIA research published in 2019 that focused on developing treatment plans for lung and head and neck cancer.

“Our AI can cut out much of the back and forth that happens between the doctor and the dosage planner,” said Steve Jiang, Ph.D., who directs UT Southwestern’s MAIA Lab. “This improves the efficiency dramatically.”

A second new study by Jiang shows how AI can quickly and accurately recalculate dosages before each radiation session, taking into account how the patient’s anatomy may have changed since the last therapy. A conventional, accurate recalculation sometimes requires patients to wait for 10 minutes or more, in addition to the time needed to conduct anatomy imaging before each session. Jiang’s researchers developed an AI algorithm that combined two conventional models that had been used for dose calculation: a simple, fast model that lacked accuracy and a complex one that was accurate but required a much longer time, often about a half-hour. The newly developed AI assessed the differences between the models – based on data from 70 prostate cancer patients – and learned how to utilize both speed and accuracy to generate calculations within one second.

UT Southwestern plans to use the new AI capabilities in clinical care after implementing a patient interface. Meanwhile, the MAIA Lab is developing deep-learning tools for several other purposes, including enhanced medical imaging and image processing, automated medical procedures, and improved disease diagnosis and treatment outcome prediction.

Related Links:
MAIA Lab


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.